ClinConnect ClinConnect Logo
Search / Trial NCT05614687

Art as Healing: A Community-informed Art-based Programme (CiAbP) for Reintegrating Ex-offenders Into Society in Nigeria

Launched by TEESSIDE UNIVERSITY · Nov 5, 2022

Trial Information

Current as of July 26, 2025

Not yet recruiting

Keywords

Trauma Anxiety And Fear

ClinConnect Summary

This clinical trial, called "Art as Healing," is exploring how an art-based program can help people affected by crime, including ex-offenders, heal from trauma and improve their reintegration into society in Nigeria. The study aims to understand if this Community-informed Art-based Programme (CiAbP) can positively change community attitudes towards ex-offenders and help them feel more accepted. Participants will be divided into two groups: one will participate in the CiAbP, which includes activities like storytelling, poetry, and drawing, while the other group will receive standard government messages without the art component. Researchers will compare the experiences and attitudes of both groups to see which approach is more effective.

To be eligible for this trial, participants should be at least 18 years old, live in areas like Lagos or Delta states, have experienced trauma, and be able to speak English. They will need to provide consent and participate in surveys before the program, after it ends, and again three months later to track any changes. This study is not yet recruiting participants, but it aims to help communities better understand and support those who have faced challenges related to crime and reintegration.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Community members with previous experience of trauma
  • Aged 18+ years and are residents in areas including Lagos/Delta states and its environs.
  • Able to give informed consent,
  • Speak the English language,
  • Able to partake in baseline, pre-, post- and three-month follow-up data collection.
  • Exclusion Criteria:
  • The exclusion criteria are those not meeting the study's inclusion criteria.

About Teesside University

Teesside University is a leading higher education institution dedicated to advancing research and innovation in various fields, including healthcare and clinical studies. With a strong emphasis on collaboration and community engagement, the university fosters a dynamic environment for clinical trials that aim to improve patient outcomes and contribute to the body of medical knowledge. Through its state-of-the-art facilities and a multidisciplinary team of researchers, Teesside University actively supports the development and implementation of cutting-edge clinical research initiatives, ensuring adherence to the highest ethical and regulatory standards.

Locations

Patients applied

0 patients applied

Trial Officials

Tarela Ike, Dr

Principal Investigator

Teesside University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials